Huaibin Zhou

1.1k total citations
35 papers, 811 citations indexed

About

Huaibin Zhou is a scholar working on Molecular Biology, Cancer Research and Clinical Biochemistry. According to data from OpenAlex, Huaibin Zhou has authored 35 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Clinical Biochemistry. Recurrent topics in Huaibin Zhou's work include Mitochondrial Function and Pathology (13 papers), ATP Synthase and ATPases Research (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Huaibin Zhou is often cited by papers focused on Mitochondrial Function and Pathology (13 papers), ATP Synthase and ATPases Research (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Huaibin Zhou collaborates with scholars based in China, United States and Belarus. Huaibin Zhou's co-authors include Jianxin Lyu, Hezhi Fang, Qing H. Meng, Lijun Shen, Jianghui Li, Guoqiang Tan, Bingqian Wang, Huangen Ding, Guorong Chen and Jianxin Lü and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Diabetes.

In The Last Decade

Huaibin Zhou

35 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaibin Zhou China 17 510 214 102 67 62 35 811
Hyewon Kong United States 5 643 1.3× 279 1.3× 53 0.5× 89 1.3× 53 0.9× 5 946
Brian Cunniff United States 14 582 1.1× 134 0.6× 53 0.5× 95 1.4× 91 1.5× 28 915
Ning Shen China 18 587 1.2× 91 0.4× 61 0.6× 122 1.8× 92 1.5× 39 941
Zhiquan Chen China 20 495 1.0× 130 0.6× 60 0.6× 69 1.0× 82 1.3× 37 910
Dong‐Chan Park South Korea 11 357 0.7× 168 0.8× 30 0.3× 98 1.5× 43 0.7× 20 781
Wenjuan Fu China 18 439 0.9× 264 1.2× 39 0.4× 29 0.4× 115 1.9× 42 995
Keshav K. Singh United States 10 458 0.9× 182 0.9× 36 0.4× 127 1.9× 35 0.6× 13 681
Laurie Tsuruda United States 14 576 1.1× 130 0.6× 107 1.0× 196 2.9× 59 1.0× 20 1.2k
Kaori Endo Japan 17 548 1.1× 144 0.7× 31 0.3× 49 0.7× 37 0.6× 47 1.2k

Countries citing papers authored by Huaibin Zhou

Since Specialization
Citations

This map shows the geographic impact of Huaibin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaibin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaibin Zhou more than expected).

Fields of papers citing papers by Huaibin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaibin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaibin Zhou. The network helps show where Huaibin Zhou may publish in the future.

Co-authorship network of co-authors of Huaibin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Huaibin Zhou. A scholar is included among the top collaborators of Huaibin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaibin Zhou. Huaibin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Qing, et al.. (2025). SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin. Journal of Cancer Research and Clinical Oncology. 151(2). 55–55. 1 indexed citations
2.
Liu, Mi, Denghao Li, Di Cui, et al.. (2025). A NIR-II Laser-Triggered Nb2C-Arg/Gel Composite Multifunctional Hydrogel with Photothermal, ROS Scavenging, and NO Release for Infected Wound Healing. Langmuir. 41(26). 17104–17116. 1 indexed citations
3.
Zhu, Hui, et al.. (2024). The essential role of adenine nucleotide translocase 4 on male reproductive function in mice. Brazilian Journal of Medical and Biological Research. 57. 3 indexed citations
4.
Pang, Yilin, Guoqiang Tan, Yao Chen, et al.. (2021). Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma. Cancer Cell International. 21(1). 463–463. 14 indexed citations
5.
Gao, Feng, Bin Li, Haifeng Chen, et al.. (2021). GRP75 Regulates Mitochondrial-Supercomplex Turnover to Modulate Insulin Sensitivity. Diabetes. 71(2). 233–248. 21 indexed citations
6.
Du, Miaomiao, Jie Xie, Yan Zhou, et al.. (2020). Mutations in TOMM70 lead to multi-OXPHOS deficiencies and cause severe anemia, lactic acidosis, and developmental delay. Journal of Human Genetics. 65(3). 231–240. 24 indexed citations
7.
Pang, Yilin, Jianghui Li, Feng Liang, et al.. (2020). Development of a Sensitive Escherichia coli Bioreporter Without Antibiotic Markers for Detecting Bioavailable Copper in Water Environments. Frontiers in Microbiology. 10. 3031–3031. 11 indexed citations
8.
Du, Miaomiao, Dongxiao Li, Jie Xie, et al.. (2020). Mutations inFASTKD2are associated with mitochondrial disease with multi‐OXPHOS deficiency. Human Mutation. 41(5). 961–972. 27 indexed citations
9.
Wang, Weilong, Yilin Pang, Huaibin Zhou, et al.. (2020). A simple and rapid protein purification method based on cell-surface display of SUMO-fused recombinant protein and Ulp1 protease. AMB Express. 10(1). 65–65. 11 indexed citations
10.
Zhang, Kun, Haifeng Chen, Yue Yang, et al.. (2020). Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models. 动物学研究. 41(5). 539–551. 10 indexed citations
11.
Wang, Kejie, Congjie Zhang, Huaibin Zhou, et al.. (2018). Enhanced ROS production leads to excessive fat accumulation through DAF-16 in Caenorhabditis elegans. Experimental Gerontology. 112. 20–29. 37 indexed citations
12.
Wang, Qiufeng, Shujie Song, Liyan Li, et al.. (2018). Oncocytic tumors are marked by enhanced mitochondrial content and mtDNA mutations of complex I in Chinese patients. Mitochondrion. 45. 1–6. 9 indexed citations
13.
Zhou, Chao, Hongwei Sun, Jing Gao, et al.. (2018). Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth. Cell Death and Disease. 9(2). 161–161. 90 indexed citations
14.
Zhou, Huaibin, et al.. (2017). Generation and Bioenergetic Profiles of Cybrids with East Asian mtDNA Haplogroups. Oxidative Medicine and Cellular Longevity. 2017(1). 1062314–1062314. 14 indexed citations
15.
16.
Guo, Yi, Yuning Zhang, Panpan Lu, et al.. (2015). Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2. Cancer Biology & Therapy. 17(2). 169–180. 58 indexed citations
17.
Nie, Hezhongrong, Guorong Chen, Jing He, et al.. (2015). Mitochondrial common deletion is elevated in blood of breast cancer patients mediated by oxidative stress. Mitochondrion. 26. 104–112. 26 indexed citations
18.
Xiao, Yang, Wei Li, Huaibin Zhou, et al.. (2014). Down-Regulation of mir-221 and mir-222 Restrain Prostate Cancer Cell Proliferation and Migration That Is Partly Mediated by Activation of SIRT1. PLoS ONE. 9(6). e98833–e98833. 70 indexed citations
19.
Li, Xiang, et al.. (2013). Self-assembled HCV core virus-like particles targeted and inhibited tumor cell migration and invasion. Nanoscale Research Letters. 8(1). 401–401. 10 indexed citations
20.
Zhang, Jie, Huaibin Zhou, Longyi Zhang, et al.. (2013). The −590C/T polymorphism in the IL-4 gene and the risk of cancer: a meta-analysis. Tumor Biology. 34(4). 2261–2268. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyewon Kong Breakdown of academic impact, for papers by Brian Cunniff Breakdown of academic impact, for papers by Ning Shen Breakdown of academic impact, for papers by Zhiquan Chen Breakdown of academic impact, for papers by Dong‐Chan Park Breakdown of academic impact, for papers by Wenjuan Fu Breakdown of academic impact, for papers by Keshav K. Singh Breakdown of academic impact, for papers by Laurie Tsuruda Breakdown of academic impact, for papers by Kaori Endo
Rankless by CCL
2026